Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheadle

Showing results (661-670 of 729) with videos related to

Pageof 73
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 20, 2012
Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutationsMadson Q Almeida, Monalisa F Azevedo, Paraskevi Xekouki, et al.
The Journal of Clinical Investigation|December 21, 2011
Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in miceMegan Podowski, Carla Calvi, Shana Metzger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigensRyan D Guest, Robert E Hawkins, Natalia Kirillova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximabChristopher G Smith, David Fisher, Bart Claes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2015
Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway BlockadeJanis M Taube, Geoffrey D Young, Tracee L McMiller, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2025
Systemic complement protein levels as biomarkers of chemoradiotherapy response in anal squamous cell carcinomaD Majorova, R Samuel, R Muirhead, et al.
Cancer Research|October 3, 2014
Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockadeSimon J Dovedi, Amy L Adlard, Grazyna Lipowska-Bhalla, et al.
Mucosal Immunology|October 31, 2025
CCR2-driven monocyte recruitment is protective against radiotherapy-induced intestinal toxicityNabina Pun, Urszula M Cytlak, Dave Lee, et al.
Haematologica|September 3, 2013
Investigation of the role of interleukin-6 and hepcidin antimicrobial peptide in the development of anemia with ageBryan J McCranor, Jacqueline M Langdon, Olivier D Prince, et al.
Oncoimmunology|June 19, 2023
Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1Debayan Mukherjee, Erminia Romano, Richard Walshaw, et al.
Pageof 73

Showing results (661-670 of 729) with videos related to

Sort By:
Pageof 73
The Journal of Clinical Endocrinology and Metabolism|January 20, 2012
Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutationsMadson Q Almeida, Monalisa F Azevedo, Paraskevi Xekouki, et al.
The Journal of Clinical Investigation|December 21, 2011
Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in miceMegan Podowski, Carla Calvi, Shana Metzger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigensRyan D Guest, Robert E Hawkins, Natalia Kirillova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2013
Somatic profiling of the epidermal growth factor receptor pathway in tumors from patients with advanced colorectal cancer treated with chemotherapy ± cetuximabChristopher G Smith, David Fisher, Bart Claes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2015
Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway BlockadeJanis M Taube, Geoffrey D Young, Tracee L McMiller, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2025
Systemic complement protein levels as biomarkers of chemoradiotherapy response in anal squamous cell carcinomaD Majorova, R Samuel, R Muirhead, et al.
Cancer Research|October 3, 2014
Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockadeSimon J Dovedi, Amy L Adlard, Grazyna Lipowska-Bhalla, et al.
Mucosal Immunology|October 31, 2025
CCR2-driven monocyte recruitment is protective against radiotherapy-induced intestinal toxicityNabina Pun, Urszula M Cytlak, Dave Lee, et al.
Haematologica|September 3, 2013
Investigation of the role of interleukin-6 and hepcidin antimicrobial peptide in the development of anemia with ageBryan J McCranor, Jacqueline M Langdon, Olivier D Prince, et al.
Oncoimmunology|June 19, 2023
Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1Debayan Mukherjee, Erminia Romano, Richard Walshaw, et al.
Pageof 73